These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 6129135

  • 1. Long term elevations in plasma thyrotropin, but not growth hormone, concentrations associated with lesion-induced depletion of median eminence somatostatin.
    Urman S, Critchlow V.
    Endocrinology; 1983 Feb; 112(2):659-64. PubMed ID: 6129135
    [Abstract] [Full Text] [Related]

  • 2. Effects of hypothalamic periventricular lesions on pulsatile growth hormone secretion.
    Urman S, Kaler L, Critchlow V.
    Neuroendocrinology; 1985 Nov; 41(5):357-62. PubMed ID: 2865689
    [Abstract] [Full Text] [Related]

  • 3. Somatostatin content of the median eminence in female rats with lesion-induced disruption of the inhibitory control of growth hormone secretion.
    Critchlow V, Rice RW, Abe K, Vale W.
    Endocrinology; 1978 Sep; 103(3):817-25. PubMed ID: 744118
    [Abstract] [Full Text] [Related]

  • 4. Effect of lesions in the periventricular nucleus of the preoptic-anterior hypothalamus on growth hormone and thyrotropin secretion and brain somatostatin.
    Critchlow V, Abe K, Urman S, Vale W.
    Brain Res; 1981 Oct 19; 222(2):267-76. PubMed ID: 6116518
    [Abstract] [Full Text] [Related]

  • 5. Regulation of growth hormone and thyrotropin secretion by somatostatin systems in rat brain.
    Terry LC, Crowley WR.
    Neuroendocrinology; 1986 Oct 19; 42(3):218-25. PubMed ID: 2869424
    [Abstract] [Full Text] [Related]

  • 6. Effects of periventricular lesions on the release of somatostatin during perifusion.
    Kaler LW, Dyke A, Critchlow V.
    Brain Res; 1986 Oct 29; 386(1-2):175-82. PubMed ID: 2877715
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Role of somatostatin in the acute immobilization stress-induced GH decrease in rat.
    Benyassi A, Gavaldà A, Armario A, Arancibia S.
    Life Sci; 1993 Oct 29; 52(4):361-70. PubMed ID: 8093630
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Evidence that the regulation of growth hormone secretion is mediated predominantly by a growth hormone releasing factor.
    Willoughby JO, Koblar S, Jervois PM, Menadue MF, Oliver JR.
    Neuroendocrinology; 1983 May 29; 36(5):358-63. PubMed ID: 6134246
    [Abstract] [Full Text] [Related]

  • 16. Effects of somatostatin antiserum on growth hormone levels in rats with periventricular lesions in the anterior hypothalamus.
    Kaler LW, Vale W, Critchlow V.
    Brain Res; 1988 May 03; 447(2):384-8. PubMed ID: 2898964
    [Abstract] [Full Text] [Related]

  • 17. On the mechanism of growth hormone autofeedback regulation: possible role of somatostatin and growth hormone-releasing factor.
    Conway S, McCann SM, Krulich L.
    Endocrinology; 1985 Dec 03; 117(6):2284-92. PubMed ID: 2866085
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.